AI‑designed intracellular antibody fragments can stay stable inside cells and bind misfolded proteins, opening new treatment ...

Integral Molecular, the industry leader in the discovery and engineering of antibodies against membrane proteins, announces ...

Prothena Corporation plc (NASDAQ:PRTA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to coramitug, a potential best-in-class amyloid depleter ...

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...

A new treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The ...

I have been following the story here of the newest Alzheimers drugs, the first to show that they can actually slow the ...

Apr 27, 2026--Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that th ...

Program provides access to leronlimab for patients with limited treatment options while supporting ongoing clinical developmentVANCOUVER, ...

Study of CAL101, which targets a novel upstream pathway implicated in fibrotic disease, enrolls 161 patients more than six months ahead of plan; topline data expected Q1 2027 Drug candidate, a ...

B cells are white blood cells that form a core part of the body's adaptive immune system, enabling it to recognize specific ...

Both Seaport Therapeutics and Hemab Therapeutics are hoping to bring in around $180 million each from their public listings ...

Nantes, France, April 27, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today welcomes the announcement by its ...